<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
70277-503-02
</NDCCode>
<PackageDescription>
14 TABLET in 1 BOTTLE (70277-503-02)
</PackageDescription>
<NDC11Code>
70277-0503-02
</NDC11Code>
<ProductNDC>
70277-503
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Pemigatinib
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20200420
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Lonza Tampa LLC
</LabelerName>
<SubstanceName>
PEMIGATINIB
</SubstanceName>
<StrengthNumber>
13.5
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-12-16
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20-APR-20
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>